Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Naleway

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
MMWR. Morbidity and Mortality Weekly Report|June 17, 2021
COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021Hilda Razzaghi, Mehreen Meghani, Cassandra Pingali, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2018
Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016Mark G Thompson, Jeffrey C Kwong, Annette K Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Determinants of <i>de novo</i> B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Nature Immunology|May 27, 2025
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
The Journal of Infectious Diseases|November 12, 2024
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential WorkersJosephine Mak, Sana Khan, Amadea Britton, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
MMWR. Morbidity and Mortality Weekly Report|June 17, 2021
COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021Hilda Razzaghi, Mehreen Meghani, Cassandra Pingali, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2018
Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016Mark G Thompson, Jeffrey C Kwong, Annette K Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Determinants of <i>de novo</i> B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Nature Immunology|May 27, 2025
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
The Journal of Infectious Diseases|November 12, 2024
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential WorkersJosephine Mak, Sana Khan, Amadea Britton, et al.
Pageof 6